Tag: PAE

Nigeria

First prostate artery embolization performed in Nigeria

Hammed Ninalowo (Lagos, Nigeria) and Scott McLafferty (Columbus Radiology Corporation, Cincinnati, USA) performed the first prostate artery embolization (PAE) in Nigeria on 29 August...
PAE

Rebuttal from IR community as AUA continues to not recommend PAE...

The American Urological Association (AUA) have published guideline amendments in the September issue of The Journal of Urology, but have not changed their stance...

Balloon-occlusion PAE as effective as conventional microcatheter PAE

Balloon-occlusion prostatic artery embolization (PAE) is as effective as conventional microcatheter PAE in the treatment of benign prostatic hyperplasia (BPH) with a potential to...
microspheres

Using smaller microspheres does not improve PAE outcomes

Prostate artery embolization (PAE) outcomes do not differ significantly when microspheres of different sizes are used as embolic agents, a recent single centre, randomised...
PAE

IR community backs PAE and calls for close collaboration with urologists

Current evidence supports the use of prostate artery embolization (PAE) as a safe, effective, and minimally-invasive treatment for the symptoms of benign prostatic hyperplasia...

The future of interventional radiology rests on the creativity and innovation...

Described by her supervisor Glen Schlaphoff (Sydney, Australia) as "a perfect example of a young up and coming interventional radiologist", Sindhura Nirmalarajan is a...
randomised

US IDE trial finds embolization “safe and efficacious” for benign prostatic...

A prospective US FDA-approved investigational device exemption (IDE) study has demonstrated significant improvement in lower urinary tract symptoms secondary to benign prostatic hyperplasia and...
Purple Embozene microspheres

Embozene microspheres are now indicated for prostate artery embolization

Boston Scientific showed at the Global Embolization Cancer Symposium and Technologies (GEST US; 17–19 May, Miami Beach, USA) meeting that the US Food and...
embolization

UK NICE’s recommendation of prostatic artery embolization is a “huge development”

https://www.youtube.com/watch?v=QH9H-hwdb6o&feature=youtu.be Francesco Carnevale (São Paulo, Brazil) speaks on the growing acceptance for prostatic artery embolization. The national regulatory bodies in Brazil and the UK recommending...

Multicentre UK registry results highlight embolization strengths and importance of physician...

First results from the UK-ROPE multicentre registry reveal that prostatic artery embolization is highly effective in reducing lower urinary tract symptoms in men with benign prostatic obstruction.

Randomised trial finds prostatic artery embolization “a real treatment alternative” to...

Six-month results from a prospective, randomised, non-inferiority study presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE; 16–20 September, Copenhagen, Denmark) reveal...

Embosphere receives US FDA de novo classification for prostatic artery embolization

Merit Medical has announced that it has received 513(f)(2) (de novo) classification from the FDA to expand indication for its Embosphere microspheres. The indication...

High radiation dose to operator with prostatic artery embolization, until imaging...

According to our results, the physician who performs prostatic artery embolization procedures, even with a ceiling suspended shield, would reach the annual radiation limit...

Study suggests adenomatous-dominant benign prostatic hyperplasia could predict successful embolization

A study recently published in Cardiovascular and Interventional Radiology has, for the first time, identified adenomatous-dominant benign prostatic hyperplasia as a predictor of clinical...

1,000-patient study indicates prostate artery embolization remains effective for years

Prostate artery embolization maintains its effectiveness for at least three years after patients undergo the therapy, according to research presented at the Society of...

Mentice releases world’s first endovascular simulation training software module for prostatic...

Mentice has announced the release of the world’s first simulation training software module for prostatic artery embolization. The software, created from real patients’ data,...